Attention APWCA Members & Stakeholders:
CALL TO ACTION
We need your voice once again!
A peer-reviewed manuscript accepted to be published in the Journal of Wound Care The hidden costs of limiting access: clinical and economic risks of Medicare’s future effective cellular, acellular and matrix-like products (CAMPs) Local Coverage Determination – has become available and makes it clear: Medicare’s forthcoming LCD “Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers,” set to take effect April 13, 2025, will cause significant harm to the patients we serve.
This policy imposes a rigid cap of eight CAMP applications over a 16-week episode of care regardless of clinical response. As providers on the front lines of wound care, we know this will:
- Worsen outcomes by increasing amputations, hospitalizations, and ED visits
- Restrict access for the most vulnerable Medicare beneficiaries
- Prevent physicians from exercising clinical judgment and practicing according to training
- Ignore critical real-world evidence that proves the value of these treatments
While the Alliance of Wound Care Stakeholders recently voiced support for the LCD, the APWCA strongly disagrees with its current form and urges Congress to intervene. Our patients deserve better.
What You Can Do
We’re asking every APWCA member to email one or more of the Congressional contacts listed below and urge them to oppose this future effective LCD as written. Tell them it puts patients at risk, undermines medical practice, and widens disparities.
Personalize your message with:
- Your experience treating hard-to-heal wounds
- The impact of CAMPs on patient outcomes
- Your concerns with a one-size-fits-all reimbursement cap
Legislators the APWCA Encourages Our Members to Contact – Organized by State
Alabama
- Sen. Katie Britt – maggie_mcpherson@britt.senate.gov
- Rep. Dale Strong – sophia.warner@mail.house.gov
California
- Sen. Alex Padilla – john_chambliss@padilla.senate.gov
Colorado
- Rep. Diana DeGette – david.steury@mail.house.gov
Florida
- Rep. Neal Dunn – tucker.williamson@mail.house.gov
- Rep. Gus Bilirakis – chris.jones@mail.house.gov
- Rep. Sheila Cherfilus-McCormick – angelle.kwemo@mail.house.gov
- Sen. Rick Scott – thomas_power@rickscott.senate.gov
Georgia
- Rep. Rich McCormick – ayush.nallapally@mail.house.gov
- Rep. Rich McCormick – lizzie.orr@mail.house.gov (additional contact)
Indiana
- Sen. Jim Banks – Elle_Rogers@banks.senate.gov
Iowa
- Rep. Mariannette Miller-Meeks – blake.thelander@mail.house.gov
Massachusetts
- Rep. Jake Auchincloss – jess.wysocky@mail.house.gov
Minnesota
- Rep. Pete Stauber – Sean.Sullivan@mail.house.gov
- Rep. Tom Emmer – Liz.Stinebaugh@mail.house.gov
Missouri
- Sen. Josh Hawley – Alex_Lawrence@hawley.senate.gov
- Rep. Jason Smith – Ari.Kirsh@mail.house.gov
New York
- Rep. Claudia Tenney – jack.boyd@mail.house.gov
North Carolina
- Sen. Thom Tillis – garrett_daniel@tillis.senate.gov
Pennsylvania
- Rep. Dan Meuser – joseph.arbie@mail.house.gov
- Sen. John Fetterman – caroline_shaffer@fetterman.senate.gov
- Rep. Mary Gay Scanlon – emily.kastenberg@mail.house.gov
- Rep. Mike Kelly – alex.sells@mail.house.gov
Tennessee
- Rep. Chuck Fleischmann – ian.merritt@mail.house.gov
- Rep. Diana Harshbarger – peter.stein@mail.house.gov
Texas
- Rep. Dan Crenshaw – colin.yokanovich@mail.house.gov
- Rep. Nathaniel Moran – cruz.perez@mail.house.gov
- Rep. Brandon Gill – graham.wise@mail.house.gov
- Rep. Joaquin Castro – eyole.mbongo@mail.house.gov
- Rep. Tony Gonzales – david.maestas@mail.house.gov
- Rep. Beth Van Duyne – brayden.woods@mail.house.gov
- Sen. John Cornyn – Jeffrey_Last@cornyn.senate.gov
- Sen. Ted Cruz – maura_mcnamara@cruz.senate.gov
- Rep. Marc Veasey – Sequoia.Ragland@mail.house.gov
Utah
- Sen. Mike Lee – ryan_neuhaus@lee.senate.gov
- Rep. Burgess Owens – cody.rowe@mail.house.gov
Let Congress hear from the clinicians who know the risks best. Contact them today—before April 13.
Thank you for your dedication to evidence-based care and patient advocacy.
